Keywords: reopro, plus, retavase, mi, myocardial, infarction, patients

ReoPro plus Retavase in MI

Article | 21 June 2000

Myocardial infarction patients administered a dual regimen of EliLilly/Centocor's ReoPro (abciximab) and Centocor's new-generation thrombolytic Retavase (reteplase) are more ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Retavase

Reteplase

Abciximab

ReoPro

Go to drug listing